Breaking News

Colorectal Cancer Screening Offers a Net Benefit

May 19, 2021 • 1:28 pm CDT
(Vax Before Cancer)

The US Preventive Services Task Force (USPSTF) announced on May 18, 2021, it has published a final recommendation statement on screening for colorectal cancer. It has concluded with high certainty that screening for colorectal cancer in adults aged 50 to 75 years has a substantial net benefit (B rating).

Overall, people 45 to 75 should be screened to reduce their risk of dying from this disease. For adults 76 to 85, the Task Force recommends that the decision to screen be made individually.

Colorectal cancer is the third leading cause of cancer death for both men and women, with an estimated 52,980 persons in the US projected to die of colorectal cancer in 2021. It is estimated that 10.5% of new colorectal cancer cases occur in persons younger than 50 years.

In 2018, about 31% of eligible people were not up to date with screening.

Recommendations made by the Washington DC-based USPSTF are independent of the U.S. government. They should not be construed as an official position of the Agency for Healthcare Research and Quality or the U.S. Department of Health and Human Services.